These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 28282270)

  • 41. Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.
    Kao D; Roach B; Silva M; Beck P; Rioux K; Kaplan GG; Chang HJ; Coward S; Goodman KJ; Xu H; Madsen K; Mason A; Wong GK; Jovel J; Patterson J; Louie T
    JAMA; 2017 Nov; 318(20):1985-1993. PubMed ID: 29183074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stable core virome despite variable microbiome after fecal transfer.
    Broecker F; Russo G; Klumpp J; Moelling K
    Gut Microbes; 2017 May; 8(3):214-220. PubMed ID: 27935413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.
    Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS
    Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.
    Walia R; Garg S; Song Y; Girotra M; Cuffari C; Fricke WF; Dutta SK
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):565-70. PubMed ID: 25023578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing the fecal microbiota of infants with botulism.
    Shirey TB; Dykes JK; Lúquez C; Maslanka SE; Raphael BH
    Microbiome; 2015 Nov; 3():54. PubMed ID: 26593441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
    Newman KM; Rank KM; Vaughn BP; Khoruts A
    Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
    Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
    [No Abstract]   [Full Text] [Related]  

  • 49. Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent
    Azimirad M; Jo Y; Kim MS; Jeong M; Shahrokh S; Asadzadeh Aghdaei H; Zali MR; Lee S; Yadegar A; Shin JH
    J Inflamm Res; 2022; 15():105-116. PubMed ID: 35023946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
    Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
    Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Ianiro G; Punčochář M; Karcher N; Porcari S; Armanini F; Asnicar F; Beghini F; Blanco-Míguez A; Cumbo F; Manghi P; Pinto F; Masucci L; Quaranta G; De Giorgi S; Sciumè GD; Bibbò S; Del Chierico F; Putignani L; Sanguinetti M; Gasbarrini A; Valles-Colomer M; Cammarota G; Segata N
    Nat Med; 2022 Sep; 28(9):1913-1923. PubMed ID: 36109637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
    Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection.
    Seekatz AM; Rao K; Santhosh K; Young VB
    Genome Med; 2016 Apr; 8(1):47. PubMed ID: 27121861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection.
    Li X; Gao X; Hu H; Xiao Y; Li D; Yu G; Yu D; Zhang T; Wang Y
    Front Microbiol; 2018; 9():2622. PubMed ID: 30450088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
    Hui W; Li T; Liu W; Zhou C; Gao F
    PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection.
    Chehri M; Christensen AH; Halkjær SI; Günther S; Petersen AM; Helms M
    Medicine (Baltimore); 2018 Aug; 97(31):e11706. PubMed ID: 30075573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacteriophage transfer during faecal microbiota transplantation in
    Zuo T; Wong SH; Lam K; Lui R; Cheung K; Tang W; Ching JYL; Chan PKS; Chan MCW; Wu JCY; Chan FKL; Yu J; Sung JJY; Ng SC
    Gut; 2018 Apr; 67(4):634-643. PubMed ID: 28539351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.
    Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z
    Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.